Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE Six markers associated with early-onset prostate cancer [rs2171492 (7q32), rs6983561 (8q24), rs10993994 (10q11), rs4430796 (17q12), rs1799950 (17q21), and rs266849 (19q13)] were genotyped. 22144497

2012

dbSNP: rs10993994
rs10993994
T 0.800 GeneticVariation GWASCAT 12 new susceptibility loci for prostate cancer identified by genome-wide association study in Japanese population. 31562322

2019

dbSNP: rs10993994
rs10993994
T 0.800 GeneticVariation GWASCAT Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies. 24753544

2014

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE In conclusion, in a small case-control study of prostate cancer cases from Utah high-risk pedigrees, we have significantly replicated association of prostate cancer with rs10993994</span> (10q11) upon study-wide correction for multiple comparisons. 19336566

2009

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE The rs10993994 genotype in the MSMB gene modifies the association between number of sexual partners and PCa risk. 24037734

2013

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE Rs11672691 and rs10993994 were associated with both fatal and nonfatal PCa, while rs6465657, rs7127900, rs2735839, and rs13385191 were associated with nonfatal PCa only. 24411283

2014

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine. 20967219

2010

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE BACKGROUND.With recent advances in high-throughput sequencing technologies, many prostate cancer risk loci have been identified, including rs10993994, a single nucleotide polymorphism (SNP) located near the MSMB gene. 24464504

2014

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE Further investigation is warranted to determine whether rs10993994 alone or in combination with additional variants contributes to prostate cancer susceptibility. 19383797

2009

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE The observations that rs10993994 is the strongest associated variant in the region and its risk allele has a major effect on the transcriptional activity of MSMB, a gene with previously described prostate cancer suppressor function, together suggest the T allele of rs10993994 as a potential causal variant at 10q11 that confers increased risk of prostate cancer. 19153072

2009

dbSNP: rs10993994
rs10993994
0.800 GeneticVariation BEFREE Genome-wide association studies (GWAS) have established a variant, rs10993994, on chromosome 10q11 as being associated with prostate cancer risk. 21085629

2010

dbSNP: rs10993994
rs10993994
T 0.800 GeneticVariation GWASCAT Genome-wide association scan for variants associated with early-onset prostate cancer. 24740154

2014

dbSNP: rs138213197
rs138213197
0.800 GeneticVariation BEFREE We performed a retrospective analysis of germline DNA samples from Ashkenazi Jewish men and a comparison group of non-Ashkenazi men treated for prostate cancer at our institution to determine the prevalence of HOXB13 G84E mutation in prostate cancer patients of Ashkenazi Jewish heritage, an ethnic group common to the New York City area. 23475555

2013

dbSNP: rs138213197
rs138213197
0.800 GeneticVariation BEFREE Our results indicated that significant increased PCa susceptibility was associated with rs138213197 compared with non-carriers (OR = 3.38, 95% CI: 2.45-4.66). 27626483

2016

dbSNP: rs138213197
rs138213197
0.800 GeneticVariation BEFREE While the HOXB13 G84E mutation may be rare, there may be a future role in genetic testing for this mutation after further studies of clinical utility in assessing prostate cancer risk. 24310616

2014

dbSNP: rs138213197
rs138213197
0.800 GeneticVariation BEFREE There was a stronger association between the G84E variant and PC among men with no first-degree relative with PC (OR, 4.04; 95% CI, 1.12-14.51) compared to men with a family history of PC (OR, 1.49; 95% CI, 0.30-7.50; P = 0.36 for interaction). 23129385

2013

dbSNP: rs138213197
rs138213197
0.800 GeneticVariation BEFREE HOXB13 G84E is prevalent in >1% of the Swedish population and is associated with a 3.5-fold increased risk of prostate cancer. 22841674

2014

dbSNP: rs138213197
rs138213197
0.800 GeneticVariation BEFREE The age-specific risk of prostate cancer among G84E mutation carriers was higher than among non-carriers. 25629170

2015

dbSNP: rs138213197
rs138213197
T 0.800 GeneticVariation GWASCAT Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. 29892016

2018

dbSNP: rs138213197
rs138213197
0.800 GeneticVariation BEFREE Testing for the G84E mutation in men with a positive family history may help distinguish those who merit more regular screening for prostate cancer. 23396964

2013

dbSNP: rs138213197
rs138213197
0.800 GeneticVariation BEFREE The prostate cancer risk allele p.G84E was identified in 18 (0.56%) of 3,187 cases and 16 (0.70%) of 2,300 controls (OR = 0.81, 95% CI = 0.41-1.59, P = 0.54). 27424772

2016

dbSNP: rs138213197
rs138213197
0.800 GeneticVariation BEFREE While there was a trend toward an earlier age at diagnosis, overall the clinicopathologic features of PCa were not significantly different in G84E carriers and non-carriers. 29181843

2018

dbSNP: rs138213197
rs138213197
0.800 GeneticVariation BEFREE The recurrent p.Gly84Glu germline mutation (G84E) in HOXB13 is consistently associated with prostate cancer (PCa), although the mechanisms underlying such linkage remain elusive. 30560549

2019

dbSNP: rs138213197
rs138213197
0.800 GeneticVariation BEFREE A rare mutation G84E in HOXB13 was recently identified to be associated with prostate cancer (PCa) in Caucasians. 22718278

2013

dbSNP: rs138213197
rs138213197
0.800 GeneticVariation BEFREE Interplay of <i>HOXB13</i> (G84E) and <i>CIP2A</i> (R229Q) variants results in highest observed inherited prostate cancer risk (OR, 21.1; <i>P</i> = 0.000024). 30181389

2018